289 related articles for article (PubMed ID: 15075294)
1. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.
Liu K; Luo Y; Lin FT; Lin WC
Genes Dev; 2004 Mar; 18(6):673-86. PubMed ID: 15075294
[TBL] [Abstract][Full Text] [Related]
2. Regulation of E2F1 by BRCT domain-containing protein TopBP1.
Liu K; Lin FT; Ruppert JM; Lin WC
Mol Cell Biol; 2003 May; 23(9):3287-304. PubMed ID: 12697828
[TBL] [Abstract][Full Text] [Related]
3. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
Yoshida K; Inoue I
Oncogene; 2004 Aug; 23(37):6250-60. PubMed ID: 15195143
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
[TBL] [Abstract][Full Text] [Related]
5. Regulation of TopBP1 oligomerization by Akt/PKB for cell survival.
Liu K; Paik JC; Wang B; Lin FT; Lin WC
EMBO J; 2006 Oct; 25(20):4795-807. PubMed ID: 17006541
[TBL] [Abstract][Full Text] [Related]
6. E2Fs link the control of G1/S and G2/M transcription.
Zhu W; Giangrande PH; Nevins JR
EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
[TBL] [Abstract][Full Text] [Related]
7. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
[TBL] [Abstract][Full Text] [Related]
8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
10. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
11. Regulation of E2F1 activity by acetylation.
Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
[TBL] [Abstract][Full Text] [Related]
12. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
[TBL] [Abstract][Full Text] [Related]
14. ASPP1 and ASPP2 are new transcriptional targets of E2F.
Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth.
Wang S; Zhang B; Faller DV
EMBO J; 2002 Jun; 21(12):3019-28. PubMed ID: 12065415
[TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
[TBL] [Abstract][Full Text] [Related]
19. Myc requires distinct E2F activities to induce S phase and apoptosis.
Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR
Mol Cell; 2001 Jul; 8(1):105-13. PubMed ID: 11511364
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
